Boven said, 'We are proud to join an established public company that has been a trusted partner in life sciences research for more than 100 years. Karl-Heinz Boven and Andreas Möller, founders of MCS, will become directors of MCS, now a subsidiary of Harvard Bioscience. Building on the momentum of these acquisitions and our existing electrophysiology business, we will leverage and further strengthen Harvard Bioscience's global sales, marketing and distribution capabilities.' Duchemin, CEO and President of Harvard Bioscience, said, 'With the acquisitions of MCS and TBSI, Harvard Bioscience becomes a true global leader in electrophysiology, an important segment in both academic research and drug discovery. Triangle BioSystems, Inc., or TBSI, was acquired for cash proceeds of approximately $1.6 million, net of acquired cash, and is a developer, manufacturer and marketer of wireless neural interface equipment to aid in vivo neuroscience research, especially in the fields of electrophysiology, psychology, neurology and pharmacology.įurther details of the acquisitions can be found in Harvard Bioscience's Form 8-K to be filed with the Securities and Exchange Commission on or about October 1, 2014.

MCS is a developer, manufacturer and marketer of instrumentation for extracellular recording and stimulation. Multi Channel Systems MCS, or MCS, was acquired for approximately 7.5 million euros in cash. Together, the acquisitions are expected to add $7.5 million to $8.5 million in revenue in 2015 and these acquisitions are expected to be accretive to 2015 earnings.

Both companies are key developers of equipment in the field of electrophysiology, and their acquisitions substantially bolster Harvard Bioscience's leadership within the electrophysiology market. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has acquired two privately held life science companies: Multi Channel Systems MCS GmbH, headquartered in Reutlingen, Germany, and Triangle BioSystems, Inc., based in Durham, North Carolina, for a total of approximately $11 million in cash. 1, 2014 (GLOBE NEWSWIRE) - Harvard Bioscience, Inc. 22.5 KBĮxpected to Add $7.5 Million to $8.5 Million in Revenue in 2015Īcquisitions of Life Science Companies in Germany and North Carolina Substantially Expands Harvard Bioscience's Electrophysiology Product Line Harvard Bioscience Acquires Multi Channel Systems MCS GmbH and Triangle BioSystems, Inc.

Multi channel systems gmbh reutlingen